Homocysteine levels correlate with AVSS-RigiScan test parameters in men with erectile dysfunction

Table 1 Comparison of clinical and laboratory data between the non-ED group and the ED group

	Non-ED group (N = 22)	ED group (N = 99)	Mann‒Whitney U	p
Age (years)	37.14 ± 1.86	49.38 ± 0.62	326.5	< 0.0001
IIEF-5	22.91 ± 0.23	11.83 ± 0.49	0	< 0.0001
EHS	2.82 ± 0.11	2.12 ± 0.07	505.5	< 0.0001
Glucose (mmol/L)	5.59 ± 0.18	6.53 ± 0.23	708.5	0.0107
TC (mmol/L)	5.38 ± 0.23	5.63 ± 0.11	930	0.2868
TG (mmol/L)	2.38 ± 0.57	2.03 ± 0.12	1028	0.6843
HDL (mmol/L)	1.08 ± 0.04	1.18 ± 0.029	865.5	0.1339
LDL (mmol/L)	3.25 ± 0.17	3.44 ± 0.09	953.5	0.3643
ApoA1 (g/L)	1.49 ± 0.04	1.51 ± 0.03	1066	0.8798
ApoB (g/L)	0.88 ± 0.04	0.96 ± 0.02	878.5	0.1581
lipoprotein(a) (mg/L)	137.1 ± 20.58	193.7 ± 18.99	997	0.5386
FMN (mmol/L)	1.84 ± 0.04	1.96 ± 0.03	760	0.0273
T (mmol/L)	21.50 ± 1.48	18.77 ± 0.74	826	0.0777
Hcys (µmol/L)	11.70 ± 0.53	14.03 ± 0.50	704	0.0098

Data are expressed as the mean ± standard deviation; P values for the ED group and non-ED group were derived from Mann‒Whitney U test (for continuous dependent variables)
ED Erectile function, IIEF-5 International Index of Erectile Function, EHS Erection Hardness Scale, TC Total cholesterol, TG Triglycerides, HLD High-density lipoprotein cholesterol, LDL Low-density lipoprotein cholesterol, ApoA1 apolipoprotein A1, ApoB Apolipoprotein B, FMN Fructosamine, T Testosterone, Hcys Homocysteine

ISSN: 2051-4190